The global clinical trial lab services market, valued at USD 4.99 billion in 2025, is projected to reach USD 5.42 billion in 2026 and USD 10.68 billion by 2035, with a CAGR of 7.8% during the forecast period 2026 to 2035. In September 2025, Global Clinical Central Lab (GCCL, South Korea), and Frontage Laboratories (US) signed a strategic Memorandum of Understanding agreement to strengthen their presence in global clinical market. Under this agreement, GCCL also leverage the complementary clinica...

The global digital age skincare market, valued at USD 66 billion in 2025, is projected to reach USD 78 billion in 2026 and USD 321 billion by 2035, with a CAGR of 17% during the forecast period 2026 to 2035. In August 2025, Revive (US) launched AI-powered skin diagnostic solution to deliver more advanced and personalized skincare solutions based on individuals requirements. In June 2025, Skin-Pal (Tiawan) launched “Skin Beauty Pal”, an AI-powered skin analysis app in Indian skincare market a...

The point of care diagnostics market size is estimated to grow from USD 1.78 billion in 2024 to reach USD 1.98 billion in 2025 and USD 5.29 billion by 2035, representing a CAGR of 10.3% during the forecast period. Owing to the need for better diagnostic tools with high sensitivity and specificity, required for timely diagnosis and better treatment, the diagnostics industry has witnessed the emergence of point of care diagnostic solutions.

The flow cytometry services market, valued at USD 3.74 billion in 2025, is projected to reach USD 4.10 billion in 2026 and USD 9.23 billion by 2035, with a 9.44% CAGR during the forecast period 2026 to 2035. High demand of flow cytometry analysis for various applications in the medical industry, coupled with stringent regulatory guidelines, has driven the need for advanced flow cytometry services that enable rapid, accurate, and high-throughput analysis of cell populations.

The global agentic AI in healthcare market, valued at USD 0.80 billion in 2025, is projected to reach USD 1.17 billion in 2026 and USD 32.76 billion by 2035, with a CAGR of 44.9% during the forecast period 2026 to 2035. Driven by the increasing demand, several market players are undertaking initiatives to agent AI that are more proactive and efficient. In order to leverage competitive edge, the market players are leveraging partnerships and collaborations. For instance, in October 2025, IBM (US)...

Researchers are currently focusing on the development of advanced stem cells, platelet-rich plasma (PRP), monoclonal antibodies (mAb), nutritional supplements, and pain management medication to improve motor function and comfort. In July 2025, Gallant (US) announced USD 18 million funding support to bring the first USFDA approved ready-to-use stem cell therapy to veterinary medicine to improve mobility in pets.

Owing to the ongoing concerns, the healthcare industry and World Health Organizations are focusing on early detection, maternal health supportive programs and treatments to promote maternal mental health. Interestingly, the market players have undertaken several initiatives to develop therapeutic drugs, women health app, mobile applications, digital health solutions for close monitoring and offering real-time support.For instance, in January 2025, Johnson & Johnson (US) announced the approval of...

The chromatography instrumentation market is estimated to grow from USD 7.9 billion in 2024 to reach USD 8.3 billion in 2025 and USD 14.1 billion by 2035, representing a higher CAGR of 5.4% during the forecast period. The liquid chromatography instruments segment led the market, capturing the largest revenue share of more than 50.0% in 2025. Further, this segment is likely to grow at a CAGR of 5.9% over the forecast period.

The 3D bioprinting market size is estimated to grow from USD 4.0 billion in 2024 to USD 23.1 billion by 2035. The market is anticipated to grow at a CAGR of 17.2%, during the forecast period till 2035. According to a recent study, over 46,500 organ transplantation procedures are annually carried out solely in the US, depicting an increase of 8.7% in the number of procedures as compared to the previous year. It is worth noting that 103,223 individuals are currently waiting for compatible organs i...

The global AI in wound care market, valued at USD 0.9 billion in 2025, is projected to reach USD 1.4 billion in 2026 and USD 16.4 billion by 2035, with a 32% CAGR during the forecast period 2026 to 2035. The market is anticipated to grow at a CAGR of 35%, during the forecast period till 2035. According to a recent study, over 10 million people suffer from various chronic and non-healing wounds in the US alone; this accounts for 2.5% of the entire population of the US. In addition, the estimates...

The cell sorting market, valued at USD 903 million in 2025 is expected to reach USD 1,078 million in 2026 and USD 3,085 million by 2035, representing a higher CAGR of 12.4% during the forecast period 2026 to 2035. Currently, the consumables and isolation kits segment dominates the market with ~60% market share and is likely to grow at a relatively higher CAGR, during the forecast period.

Digital therapeutics are clinically validated solutions that are delivered as applications, software and online programs, demonstrating the capability to facilitate positive outcomes when employed in the management of clinical conditions. A recent survey highlighted that the percentage of patients adopting digital therapeutics in the US rose from 4.7% to 18%, post the pandemic outbreak, resulting in an increased prescription rate of such therapeutics. Presently, there are more than 40 USFDA appr...

The global NAMPT inhibitor market size is estimated to be worth USD 0.2 billion in 2027 and is anticipated to reach USD 1.3 billion by 2040 at a CAGR of 15% during the forecast period. According to the American Cancer Society, in 2022, 9.7 million people died from the cancer disease globally, and 35 million new cases of cancer are predicted to be diagnosed by 2050. This mounting number of cancer cases and growing demand for effective treatment are the key drivers for market growth over this pro...

The global biosensors market, valued at USD 5.9 billion in 2025, is projected to reach USD 6.5 billion in 2026 and USD 14.0 billion by 2035, with a 9.0% CAGR during the forecast period 2026 to 2035. The growing interest in wearable devices that include biosensors for real-time health monitoring has become a significant growth factor driving the market during the forecast period. Moreover, the increasing adoption of biosensors in various medical applications is a prominent growth factor propel...

Considering the ongoing demand, several market players are undertaking initiatives for FemTech innovations in fertility and reproductive health. However, the primary focus will be on the development of personalized wellness solutions that cater to the unique requirements of women.For instance, in February 2025, LAIQA (India) launched AI-powered personalized wellness solutions for women, LAIQA. This women wellness app integrate AI technology, and wisdom of Ayurveda to monitor health concerns, suc...

The neurostimulation devices market size is likely to grow from USD 2.03 billion in 2024 to reach USD 2.24 billion in 2025 and USD 6.08 billion by 2035, representing a CAGR of 11% during the forecast period. Driven by the increasing efforts of key players in this domain, the neurostimulation devices market is anticipated to boost in the upcoming years.

Considering the ongoing demand, several market players are pursuing opportunities in bioinks such as personalized medicines, organ-on-a-chip models for streamlined drug testing, and the clinical bioprinting of organs. For instance, in March 2025, a research team at National Institute of Technology Rourkela, India has developed a bioink made with natural materials for 3D bioprinting of bone-like structures. Given the emphasis on innovations and applications of bioink in regenerative medicine, we...

The global blood brain barrier market, valued at USD 38 million in 2025, is projected to reach USD 252 million in 2026 and USD 2,904 million by 2035, with a 31.2% CAGR during the forecast period 2026 to 2035. Neurological disorders are the second highest cause of death and the leading cause of disability, worldwide. In 2021, it was reported that nearly 3.4 billion global population suffer from some form of disorder that affects the functioning of the CNS. More than 6 million people are reported...

The medical polymers market valued at USD 22.1 billion in 2025, is project to reach USD 23.5 billion in 2026 and USD 46.0 billion by 2035, representing a higher CAGR of 7.7% during the forecast period 2026 to 2035. In terms of type of polymer, the thermoplastic polymers segment holds the highest share of the market. With regards to area of application, the medical devices segment dominates the global market. Based on geographical regions, North America captures the majority of the market sha...

The global smart labels market, valued at USD 5.4 billion in 2025, is projected to reach USD 6.4 billion in 2026 and USD 24.0 billion by 2035, with a 16% CAGR during the forecast period 2026 to 2035. In terms of type of technology, the RFID segment holds the highest share (75%) of the market. With regards to type of packaging, the primary packaging segment dominates the global market with 95% market share. Based on the type of primary packaging, the syringes reagents hold the largest market shar...